Literature DB >> 23543951

Prior determination of baseline minimum alveolar concentration (MAC) of isoflurane does not influence the effect of ketamine on MAC in rabbits.

Giacomo Gianotti1, Alexander Valverde, Melissa Sinclair, Doris H Dyson, Thomas Gibson, Ron Johnson.   

Abstract

The objective of this study was to compare the effect on the minimum alveolar concentration (MAC) of isoflurane when ketamine was administered either after or without prior determination of the baseline MAC of isoflurane in rabbits. Using a prospective randomized crossover study, 8 adult, female New Zealand rabbits were allocated to 2 treatment groups. Anesthesia was induced and maintained with isoflurane. Group 1 (same-day determination) had the MAC-sparing effect of ketamine [1 mg/kg bodyweight (BW) bolus followed by a constant rate infusion (CRI) of 40 μg/kg BW per min, given by intravenous (IV)], which was determined after the baseline MAC of isoflurane was determined beforehand. A third MAC determination was started 30 min after stopping the CRI. Group 2 (separate-day determination) had the MAC-sparing effect of ketamine determined without previous determination of the baseline MAC of isoflurane. A second MAC determination was started 30 min after stopping the CRI. In group 1, the MAC of isoflurane (2.15 ± 0.09%) was significantly decreased by ketamine (1.63 ± 0.07%). After stopping the CRI, the MAC was significantly less (2.04 ± 0.11%) than the baseline MAC of isoflurane and significantly greater than the MAC during the CRI. In group 2, ketamine decreased isoflurane MAC (1.53 ± 0.22%) and the MAC increased significantly (1.94 ± 0.25%) after stopping the CRI. Minimum alveolar concentration (MAC) values did not differ significantly between the groups either during ketamine administration or after stopping ketamine. Under the study conditions, prior determination of the baseline isoflurane MAC did not alter the effect of ketamine on MAC. Both methods of determining MAC seemed to be valid for research purposes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23543951      PMCID: PMC3460604     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  32 in total

1.  Temporal summation governs part of the minimum alveolar concentration of isoflurane anesthesia.

Authors:  Robert C Dutton; Yi Zhang; Caroline R Stabernack; Michael J Laster; James M Sonner; Edmond I Eger
Journal:  Anesthesiology       Date:  2003-06       Impact factor: 7.892

2.  Effect of meloxicam and butorphanol on minimum alveolar concentration of isoflurane in rabbits.

Authors:  Patricia V Turner; Carolyn L Kerr; Amanda J Healy; W Michael Taylor
Journal:  Am J Vet Res       Date:  2006-05       Impact factor: 1.156

3.  Letter: Halothane MAC in the rabbit.

Authors:  N L Davis; R L Nunnally; T I Malinin
Journal:  Anesthesiology       Date:  1974-09       Impact factor: 7.892

4.  Electrical stimulation as a substitute for the tail clamp in the determination of minimum alveolar concentration.

Authors:  M J Laster; J Liu; E I Eger; S Taheri
Journal:  Anesth Analg       Date:  1993-06       Impact factor: 5.108

5.  Effect of intravenous administration of ketamine on the minimum alveolar concentration of isoflurane in anesthetized dogs.

Authors:  Adrian M Solano; Bruno H Pypendop; Pedro L Boscan; Jan E Ilkiw
Journal:  Am J Vet Res       Date:  2006-01       Impact factor: 1.156

6.  Expression of long-term potentiation in single wide dynamic range neurons in the rat is sensitive to blockade of glutamate receptors.

Authors:  F Svendsen; A Tjølsen; L J Rygh; K Hole
Journal:  Neurosci Lett       Date:  1999-01-04       Impact factor: 3.046

7.  Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane.

Authors:  William W Muir; Ashley J Wiese; Philip A March
Journal:  Am J Vet Res       Date:  2003-09       Impact factor: 1.156

8.  Effects of intravenous lidocaine, ketamine, and the combination on the minimum alveolar concentration of sevoflurane in dogs.

Authors:  Jeffrey Wilson; Thomas J Doherty; Christine M Egger; Andrew Fidler; Sherry Cox; Barton Rohrbach
Journal:  Vet Anaesth Analg       Date:  2008-03-19       Impact factor: 1.648

9.  Validation of several types of noxious stimuli for use in determining the minimum alveolar concentration for inhalation anesthetics in dogs and rabbits.

Authors:  Alexander Valverde; Timothy E Morey; Jorge Hernández; Wendy Davies
Journal:  Am J Vet Res       Date:  2003-08       Impact factor: 1.156

10.  Characteristics of the relationship between plasma ketamine concentration and its effect on the minimum alveolar concentration of isoflurane in dogs.

Authors:  Bruno H Pypendop; Adrian Solano; Pedro Boscan; Jan E Ilkiw
Journal:  Vet Anaesth Analg       Date:  2007-05       Impact factor: 1.648

View more
  4 in total

1.  Influence of prior determination of baseline minimum alveolar concentration (MAC) of isoflurane on the effect of ketamine on MAC in dogs.

Authors:  Giacomo Gianotti; Alexander Valverde; Ron Johnson; Melissa Sinclair; Thomas Gibson; Doris H Dyson
Journal:  Can J Vet Res       Date:  2014-07       Impact factor: 1.310

2.  The interaction of nitrous oxide and fentanyl on the minimum alveolar concentration of sevoflurane blocking motor movement (MACNM) in dogs.

Authors:  Reza Seddighi; Thomas J Doherty; Butch Kukanich; Christine M Egger; Melissa A Henn; Whitney M Long; Barton W Rohrbach
Journal:  Can J Vet Res       Date:  2014-07       Impact factor: 1.310

3.  Comparison of Systemic Effects of Midazolam, Ketamine, and Isoflurane Anaesthesia in Rabbits.

Authors:  Güneri Atalan; Gültekin Atalan; Hanifi Erol; Muharrem Erol; Ayhan Atasever; Zafer Doğan; Vehbi Güneş; M Kaan Yönez; Ihsan Keleş
Journal:  J Vet Res       Date:  2019-06-12       Impact factor: 1.744

4.  Comparison of two injectable anaesthetic protocols in Egyptian fruit bats (Rousettus aegyptiacus) undergoing gonadectomy.

Authors:  Martina Amari; Federica Alessandra Brioschi; Vanessa Rabbogliatti; Federica Di Cesare; Alessandro Pecile; Alessia Giordano; Pierangelo Moretti; William Magnone; Francesco Bonato; Giuliano Ravasio
Journal:  Sci Rep       Date:  2022-09-24       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.